FDA Eyes More Savvy Post-Approval Device Monitoring
The Food and Drug Administration on Thursday proposed ways to increase its postapproval monitoring of medical devices without having to go to Congress for more authority, focusing largely on using modern...To view the full article, register now.
Already a subscriber? Click here to view full article